Our research has demonstrated that PRM could prevent PF through modulating the high mobility group box 1 (HGMB1) and receptor for advanced glycation end-product (RAGE) pathways in vitro and in vivo9. This evidence concerns the gene HMGB1 and pemphigus foliaceus.